Heart-Safe cancer drug trial offers hope for vulnerable patients

NCT ID NCT06651970

Summary

This study is testing whether a leukemia drug called acalabrutinib is safe for people who also have moderate to severe heart problems. Researchers will compare it to other standard treatments to see which causes fewer heart-related side effects. The trial will enroll 60 adults with chronic lymphocytic leukemia and weakened heart function.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Site

    WITHDRAWN

    Charlotte, North Carolina, 28204, United States

  • Research Site

    RECRUITING

    Columbus, Ohio, 43210, United States

  • Research Site

    RECRUITING

    Philadelphia, Pennsylvania, 19104, United States

  • Research Site

    RECRUITING

    Brno, 625 00, Czechia

  • Research Site

    WITHDRAWN

    Hradec Králové, 500 05, Czechia

  • Research Site

    RECRUITING

    Prague, 10034, Czechia

  • Research Site

    RECRUITING

    Cagliari, 09121, Italy

  • Research Site

    RECRUITING

    Florence, 50134, Italy

  • Research Site

    RECRUITING

    Milan, 20122, Italy

  • Research Site

    RECRUITING

    Milan, 20132, Italy

  • Research Site

    RECRUITING

    Pavia, 27100, Italy

  • Research Site

    RECRUITING

    Perugia, 06156, Italy

  • Research Site

    RECRUITING

    Krakow, 30-727, Poland

  • Research Site

    RECRUITING

    Poznan, 60-693, Poland

  • Research Site

    RECRUITING

    Barcelona, 08003, Spain

  • Research Site

    RECRUITING

    Madrid, 28040, Spain

  • Research Site

    RECRUITING

    Seville, 41009, Spain

  • Research Site

    NOT_YET_RECRUITING

    Bournemouth, BH7 7DW, United Kingdom

  • Research Site

    RECRUITING

    Oxford, OX3 7LE, United Kingdom

  • Research Site

    RECRUITING

    Plymouth, PL6 8DH, United Kingdom

  • Research Site

    RECRUITING

    Romford, RM7 0AG, United Kingdom

  • Research Site

    WITHDRAWN

    Stockton, TS19 8PE, United Kingdom

  • Research Site

    RECRUITING

    Sutton Coldfield, B74 3UP, United Kingdom

Conditions

Explore the condition pages connected to this study.